TFS
DNA icon

TrustCore Financial Services’s Ginkgo Bioworks DNA Stock Holding History

TrustCore Financial Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.69K Hold
25
– – ﹤0.01% 911
2022
Q3 		$3K Hold
25
– – ﹤0.01% 924
2022
Q2 		$2K Hold
25
– – ﹤0.01% 940
2022
Q1 		$4K Buy
+25
New +$4.87K ﹤0.01% 883

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

TrustCore Financial Services's DNA Position: Q4 2022 in Review

TrustCore Financial Services held its Ginkgo Bioworks (DNA) position steady in Q4 2022 at 25 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #911.

TrustCore Financial Services first reported a position in DNA in Q1 2022 and has held it in 4 quarters since. The position peaked at $4K in Q1 2022. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

  • TrustCore Financial Services held 25 shares of Ginkgo Bioworks worth $1.69K as of Q4 2022.
  • TrustCore Financial Services left its Ginkgo Bioworks share count unchanged in Q4 2022.
  • Ginkgo Bioworks made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #911 holding.
  • TrustCore Financial Services first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 4 quarters since.
  • TrustCore Financial Services's Ginkgo Bioworks position peaked at $4K in Q1 2022.
  • 320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.